Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Readies Formal Complaint To WTO Over EU Generics Seizures

This article was originally published in PharmAsia News

Executive Summary

India is preparing a complaint charging the European Union with violating international trade agreements by allowing shipments of Indian-made generics headed to third countries to be seized by EU nations. The complaint is to be filed with the World Trade Organization, stating that at least 20 transhipments of generics were seized in the Netherlands and Germany, some of them for treating HIV/AIDS. The two countries claim the drugs violated laws in the EU where the patents of the branded versions are still in effect. (Click here for more - a subscription may be required

India is preparing a complaint charging the European Union with violating international trade agreements by allowing shipments of Indian-made generics headed to third countries to be seized by EU nations. The complaint is to be filed with the World Trade Organization, stating that at least 20 transhipments of generics were seized in the Netherlands and Germany, some of them for treating HIV/AIDS. The two countries claim the drugs violated laws in the EU where the patents of the branded versions are still in effect. (Click here for more - a subscription may be required)

"India Prepares EU Trade Complaint" - Wall Street Journal (U.S.) (8/6/09)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel